Category: Programs & Events

These posts feature lifestyles, events, welfare programs, perks and assistance, governmental goals, etc.

Categories
Business Lifestyle News Now! Programs & Events Science Technology

Construction begins on ‘The District at 15fifteen’ in Parsippany, NJ

New mixed-use development will bring 60,000 SF of retail space and 498 apartments to the heart of Morris County, N.J.

 

PARSIPPANY, N.J. — (BUSINESS WIRE) — A joint venture of Stanbery Development Group, Claremont Development, and PCCP, LLC has broken ground on The District at 15fifteen — a master-planned, mixed-use development in the heart of Morris County, New Jersey. New York Life Insurance Company is providing the construction loan for the project.


Located at 1515 Route 10 in Parsippany, N.J., The District at 15fifteen will feature approximately 60,000 square feet of high-end and local retailers, full and quick-service restaurants, boutique fitness and specialty services, along with a 498-unit luxury apartment community. The three-building, streetscape-style complex will serve as a one-of-a-kind destination that encourages community gatherings with year-round programming such as farmer’s markets, music in the park, food trucks, and family movie nights.

 

“By bringing new job, commercial, and housing opportunities to Parsippany, this exciting project takes a stagnant property and creates unique and vibrant possibilities that are part of the fabric making Parsippany one of the best places to live, work, and play in NJ,” said Mayor James R. Barberio.

 

The District at 15fifteen will feature 498 thoughtfully designed luxury rental homes, including 42 affordable units and 49 age-restricted units for residents 55 and over. Spread across two buildings and comprising a mix of studio, one- and two-bedroom units, phase one will be a four-story, wood-framed building with two exterior courtyards and phase two will be a five-story, wood-framed building wrapping an 853-space parking deck with one exterior courtyard. An additional 209 surface parking spaces will also be available with the option of valet parking. Both areas will service the entire development, offering easy access for both residents, retail customers and visitors.

 

The District at 15fifteen will feature high-end interior finishes and amenitized common spaces tailored to the work-from-home lifestyle. Residents will enjoy access to a full suite of resort-style, modern amenities including a fitness center, yoga studio, pool, lounge area, conference center, co-working/work-from-home options, and dog spa. The 49 age-restricted units will also include access to their own private lobby and amenities including a fitness center, co-working area, party room, and roof deck.

 

“Over the last several years we have seen Parsippany, and specifically the stretch of Route 10 between Interstate 287 and Route 202, experience an immense transformation with an influx of national retail, restaurant, and hotel options aimed at serving both residents and the large daytime worker population in Morris County,” said Marc Hays, Partner, Acquisitions and Leasing at Stanbery Development Group. “We, alongside our partners at Claremont Development and PCCP, saw an opportunity to cater to that growing need and anchor this bustling section of the Route 10 corridor with not only a high-quality, mixed-use environment, but a new, vibrant town center that cannot be found anywhere else in the region.”

 

The “pedestrian first” town center design of The District at 15fifteen will provide access for vehicles as well as pedestrian crosswalks that create a livable and walkable design for locals, visitors and the tens of thousands of workers whose headquarters and offices can be found in the area, including Wyndham Worldwide, Avis/Budget Group, Tiffany & Co. and Zoetis, among others.

 

“As young working professionals continue to seek out accommodations in nearby urban centers, suburban-based companies have been challenged with attracting and retaining a talented workforce,” said Maximilian Dorne, Partner at Claremont Development. “The District at 15fifteen will provide the amenities and modern living options millennials crave and serve as a significant tool for attracting and retaining a qualified pool of employees and employers in Parsippany and the surrounding area. The ability to seamlessly walk to the community’s commercial core for a cup of coffee, morning yoga class, business lunch, or dinner and drinks with friends, caters to this group as well as the active lifestyles of 55 and older residents. The District at 15fifteen has something for everyone.”

 

The District at 15fifteen has been approved by the New Jersey Department of Transportation to complete roadway improvements that will enhance vehicular circulation to both Route 10 East and West, as well as provide a tie-in to the Dryden Way jug handle. The road improvement will provide a direct connection to the Dryden Way ramps at Route 10 and to the office park immediately across Route 10, formerly known as the Mack-Cali office park, without so much as hitting a traffic light. The direct connection will provide a regional benefit by removing vehicle trips through the intersection of Route 10 and Route 202 while opening an alternative point of access for several other commercial properties.

 

First move-ins are slated for Fall 2024 with the retail and restaurant portions slated for completion in Fall 2025.

 

To learn more about The District at 15fifteen please visit: https://www.district1515.com/

 

About Stanbery Development Group

Stanbery Development Group is a real estate development firm specializing in the acquisition, development and redevelopment, leasing, and asset management of retail driven projects. Since our founding in 2000, Stanbery has been focused on real estate throughout the eastern United States and has developed approximately $1 billion of commercial real estate. Stanbery’s success has been built on a team with a unique blend of talent that covers all aspects of the development and redevelopment life cycle. We couple our agility and quick decision making, with the full range of industry experience and knowledge found in a large firm. As the retail climate has changed, Stanbery has adapted its core focus and now concentrates on mixed-use development, highlighting the synergies between various commercial uses such as multifamily, hotel and retail.

 

About Claremont Development

Claremont Development is a real estate development firm that focuses primarily on ground-up development of multifamily, industrial, and mixed-use projects throughout New Jersey. We leverage our in-house expertise and strategic partnerships to navigate all elements of the development and construction process in order to minimize our risks and maximize returns. Our ability to identify, acquire, entitle, design, finance and construct projects has set Claremont apart from our competitors. Our core investment strategy focuses on transit-oriented multi-family development opportunities in strong demographic locations, adaptive re-use projects in underutilized urban downtowns, strategic development projects that require substantial environmental remediation efforts, as well as underutilized / off-market properties that can be transitioned into higher density community centers or industrial space.

 

Claremont Development is responsible for over $2.0 billion of ground up development projects.

 

About PCCP, LLC

PCCP, LLC is a real estate finance and investment management firm focused on commercial real estate debt and equity investments. PCCP has $21.0 billion in assets under management on behalf of institutional investors. With offices in New York, San Francisco, Atlanta, and Los Angeles, PCCP has a 24-year track record of providing real estate owners and investors with a broad range of funding options to meet capital requirements. PCCP underwrites the entire capital stack to exploit inefficiencies in the market and provide investors with attractive risk-adjusted returns. Since its inception in 1998, PCCP has managed, raised or invested over $36.8 billion of capital through a series of investment vehicles including private equity funds, separate accounts and joint ventures. PCCP continues to seek investment opportunities with experienced operators seeking fast and reliable capital. Learn more about PCCP at www.pccpllc.com.

 

About New York Life Insurance Company

New York Life Insurance Company (www.newyorklife.com), a Fortune 100 company founded in 1845, is the largest1 mutual life insurance company in the United States and one of the largest life insurers in the world. Headquartered in New York City, New York Life’s family of companies offers life insurance, retirement income, investments, and long-term care insurance. New York Life has the highest financial strength ratings currently awarded to any U.S. life insurer from all four of the major credit rating agencies.2

 

1Based on revenue as reported by “Fortune 500 ranked within Industries, Insurance: Life, Health (Mutual),” Fortune magazine, 5/23/2022. For methodology, please see http://fortune.com/fortune500/.

 

2Individual independent rating agency commentary as of 10/18/2022: A.M. Best (A++), Fitch (AAA), Moody’s Investors Service (Aaa), Standard & Poor’s (AA+).

Contacts

MEDIA:
Sam DePasquale

Antenna | Spaces

districtat1515@antennagroup.com
(646) 935-3558

Categories
Culture Entertainment News International & World Lifestyle Programs & Events

The 2nd Annual Parade in New York City celebrates the friendship between New York and Japan

Building on the great success of last year’s inaugural Japan Parade, the 2nd annual Japan Parade in New York City was on Saturday, May 13, and began at 1 p.m.

 

Starting on Central Park West at West 81st Street and traveling south to West 67th Street, the purpose of the parade was to celebrate, express, and bring awareness to the friendship between NYC and Japan with a thank you from the Japanese community. Olympic Gold Medalist, Founder of Always Dream, and Author Kristi Yamaguchi was the Parade’s Grand Marshal.

 

This year’s Japan Parade featured a live performance by the cast of The 2.5-Dimensional show from Japan, “Live Spectacle ‘NARUTO’”. NARUTO is one of the most internationally recognized and popular manga series of all time. The franchise has sold over 250 million copies worldwide to date. Written and illustrated by creator Masashi Kishimoto, NARUTO was first published in Shueisha’s magazine Weekly Shonen Jump in 1999, where it was serialized and ran for 15 years. More performers will be announced in the coming weeks. The Japan Parade is affiliated with Japan Day @ Central Park, an annual event that has taken place in Central Park since 2007.

Concurrently with the Japan Parade, the Japan Street Fair was to be held on West 72nd Street, between Central Park West and Columbus Avenue. The Japan Street Fair is the spiritual successor of Japan Day @ Central Park.

The Japan Street Fair featured tents offering fun and educational cultural activities including calligraphy, water balloon yo-yo fishing, origami, photo opportunities, and a giveaway. In collaboration with JAPAN Fes, one of the largest organizers of Japanese food festivals in the world that hosts over 20 Japanese food fair events a year in New York City, the Street Fair should also feature about 20 tents serving authentic Japanese food. The latest information on Japan’s many tourist destinations was available at several other tents, and as with last year, there will also be a tent where visitors may donate to a charitable cause. The Japan Street Fair is your chance to experience a Japanese festival, or matsuri, unlike any other.

Kristi Yamaguchi served as the parade’s Grand Marshal, and Sandra Endo, news correspondent on KTVV Los Angeles, Fox 11 News, and a feature reporter for Good Day LA,  served as Emcee of the parade.

“I am truly honored to act as Grand Marshal for this year’s Japan Parade,” said Kristi Yamaguchi.

“My Japanese heritage is something I’m proud of and I’m happy to celebrate the goodwill of our relationship with Japan and the engagement and solidarity with the Japanese American community.”

Participating groups included Anime NYC (Anime Convention), COBU (Drum), Harlem Japanese Gospel Choir, International Karate Organization Kyokushinkaikan, The Japanese Folk Dance of NY, Katsura Sunshine (Rakugo Comedian), Midori & Friends (Music Education Group), Soh Daiko (Drum), TATE Hatoryu NY (Sword Fighting),Yosakoi Dance Project 10tecomai, Young People’s Chorus of NYC, and many more.

“The Japan Parade is a huge ‘Arigato!’ from the Japanese community to New York City,” said Honorary Chairman, Ambassador Mikio Mori, the Consul General of Japan in New York.

“It will be the second annual celebration of Japanese culture and the many vibrant connections between Japan and this great city. We plan to outdo the inaugural parade in terms of marchers, contents, and food tents all highlighting the uniqueness of Japan, while also solidifying with Asian communities during AAPI Heritage Month. We hope that these festivities bring the Japanese and all of New York City even closer together, adding to our friendship for generations to come.”

“After the huge success of last year’s inaugural Parade, we are very excited to be back in New York City for our second year, demonstrating the diversity and pride of the Japanese community,” said Japan ParadeExecutive Producer Kumiko Yoshii.

“Last year, we had a crowd of over 20,000 with approximately 2,400 participants, marching down Central Park West. We look forward to building on this success and showcasing more groups from New York and Japan. We especially want to thank our sponsors and supporters, without whom this event would not be possible.”

“The Japan Parade’s utmost goal is to be a foundation to forge new connections, and to be an inspiration to strengthen existing relations between Japan and the United States, as well as between the Japanese American community and the people of New York City,” said Japan Day Chairman of the Board of Directors, Daisuke Ugaeri, who represents the notable Japanese and Japanese American companies that make up the Japan Day Inc. Board of Directors.

“To that end, I am humbled and empowered by the invaluable support of our sponsors, the trust placed in us by our parade participants, and the tireless efforts of our staff and volunteers who all truly believe in the good our event is capable of achieving. It is my greatest hope that all who visit, experience, and immerse themselves in Japan Parade 2023 will not only enjoy themselves to the fullest, but also walk away with a newly cultivated or renewed appreciation of the unique wonder and beauty of Japanese culture.”

The very first Japan Parade and the Japan Street Fair were held in 2022. Actor, author, civil-rights activist, and influencer George Takei was the Grand Marshal for the inaugural parade. The parade’s participants included the cast of “Pretty Guardian Sailor Moon” The Super Live, as special guests from Japan, a children’s choir, taiko performers, bon-odori dance and kimono groups, Karate and other martial arts groups, and many more. Activists protesting against attacks targeting Asian citizens and anti-Asian rhetoric also marched in the parade.

The Diamond Sponsors of this year’s Japan Parade (as of 4/5) include ANA (All Nippon Airways Co., Ltd.), Hisamitsu America, Inc., Japan Airlines Co., Ltd., and Sumitomo Mitsui Trust Bank, Limited. The Platinum Sponsors (as of 4/5) include ITOCHU International Inc., Marubeni America Corporation, Mitsubishi Corporation (Americas), Mitsui & Co. (U.S.A.), Inc., Nomura America Foundation, Sumitomo Corporation of Americas Foundation, and Tokio Marine America.

MORE ABOUT KRISTI YAMAGUCHI

Kristi Yamaguchi captured the gold medal in the 1992 Winter Olympics in Albertville, France in figure skating. She is also a 2-time World champion and U.S. National Champion. Kristi is a member of the US Figure Skating Hall of Fame, the World Figure Skating Hall of Fame, and the US Olympic Hall of Fame. She recently received the USOPC’s Jesse Owens Olympic Spirit Award for “serving as a powerful force for good in society” as well as the 2019 Heisman Humanitarian Award for the work of her Always Dream organization. Following a long and successful career in professional figure skating including 10 years of touring with Stars On Ice, Kristi took to the dance floor to win the mirror ball trophy with partner Mark Ballas in season 6 of the popular TV show “Dancing With The Stars.” In 1996, she founded Kristi Yamaguchi’s Always Dream whose mission is to give children from low-income families access to high-quality books in the home environment. Aiming to close the opportunity gap and digital divide with an innovative, family engagement literacy program. www.alwaysdream.org. In 2012, Kristi added New York Times Best-Selling author to her list of achievements by introducing her first children’s picture book, “Dream Big, Little Pig!”, and then following up with “It’s A Big World, Little Pig!” and a third title “Cara’s Kindness”. Kristi resides in the San Francisco Bay Area with her husband, 2-time US Olympian and Stanley Cup Champion, Bret Hedican, and their daughters Keara and Emma.

MORE ABOUT SANDRA ENDO

Sandra Endo is a television news correspondent on KTTV Los Angeles, Fox 11 News. Endo covers breaking news in feature reports for a Good Day LA. She moved back to her hometown of Los Angeles after spending most of her career on the East Coast. Before making the move to LA, she worked for CNN based in Washington DC. Her stories have appeared on primetime shows such as AC 360 with Anderson Cooper. She also reported on the devastating tsunami and earthquake that struck Japan in 2011, as well as the international conflicts in Egypt and the US involvement in Libya. Prior to joining CNN, Endo was a political reporter, host, and anchor for NY1, covering a wide array of campaigns, the transit strike of 2005, and reporting around the clock after the September 11, 2001 terrorist attacks. A California native, Sandra is a second-generation Japanese American whose grandfather was interned during WWII. She believes it is important to teach her two young children their cultural heritage to keep traditions alive and to learn from the past.

MORE ABOUT JAPAN DAY

Japan Day Inc., a 501(c)(3) non-profit organization, is the primary organizer of the Japan Day @ Central Park festivals since 2007, and of the Japan Parade and the Japan Street Fair since 2022. Japan Day Inc.’s activities are made possible by the support of the local leading Japanese American companies that compose Japan Day Inc.’s Board of Directors, the Consulate General of Japan in New York, and all the individuals, organizations, and companies that sponsor, donate, or volunteer and be a part of this great celebration.

Categories
Healthcare Lifestyle Programs & Events Science

Teva to present data demonstrating UZEDY™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the American Psychiatric Association’s 2023 Annual Meeting

  • UZEDY significantly reduced the risk of relapse by up to 80% and prolonged the time to impending relapse by up to 5.0 times while having a similar safety profile to other formulations of risperidone1,2
  • The U.S. Food and Drug Administration (FDA) approved UZEDY on April 28, 2023 for the treatment of schizophrenia in adults as a subcutaneous injection every one or two months using a pre-filled syringe
  • Symposia on IMPACT-TD scale for tardive dyskinesia (TD) progression measurement and clinical education tool for schizophrenia, S.C.O.P.E., are also to be presented

 

TEL AVIV, Israel & PARSIPPANY, N.J. — (BUSINESS WIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),today announced that four studies across its neuroscience portfolio will be presented during the American Psychiatric Association’s (APA) 2023 Annual Meeting taking place on May 20-24, 2023. Abstracts include data for UZEDY (risperidone) extended-release injectable suspension for subcutaneous use, which was recently approved by the FDA for the treatment of schizophrenia in adults. Additional abstracts being presented include data on characteristics that impact TD diagnosis and machine-learning to identify unique patient segments for TD. TD is a chronic movement disorder that affects one in four people who take certain mental health treatments.3-5

Of the data being presented, Teva will share findings from two trials that supported the FDA approval of UZEDY, the RISE Study (The Risperidone Subcutaneous Extended-Release Study) and the SHINE Study (A Study to Test TV-46000 for Maintenance Treatment of Schizophrenia).6,7 The RISE data demonstrated that UZEDY significantly prolonged time to impending relapse by 5.0 (once-monthly dosing) and 2.7 (once-every-two-months dosing) times versus placebo in patients with schizophrenia.2 Additionally, the SHINE data confirmed the safety profile of UZEDY is consistent with other formulations of risperidone.2

 

“We’re pleased to present the foundational data that supported the FDA’s approval of UZEDY,an important new treatment option for adults with schizophrenia,” said Eric Hughes, MD, PhD, Executive Vice President of Global R&D and Chief Medical Officer at Teva. “We know schizophrenia patients experience a number of challenges when it comes to this condition, and are optimistic that UZEDY can help address the unmet needs of patients, their caregivers, and physicians.”

 

Findings from the RISE and SHINE studies demonstrate that UZEDY is efficacious with the known safety profile of risperidone. The innovative long-acting formulation of UZEDY allows for both absorption and sustained release after subcutaneous injection and is available with a range of dosing options. UZEDY utilizes SteadyTeq™, a copolymer technology proprietary to MedinCell, that controls the rate and duration of risperidone release. With this delivery system, therapeutic blood concentrations are reached within 6-24 hours of a single dose.1

 

In addition to the data, Teva will also be holding a symposium on the newly developed IMPACT-TD scale, featuring Richard Jackson, MD, Assistant Clinical Adjunct Professor, University of Michigan School of Medicine Department of Psychiatry, that may help better measure disease progression of those living with TD by taking a holistic approach to tracking social, vocational, psychological and psychiatric challenges the condition poses over time. A symposium on S.C.O.P.E. featuring John Kane, MD, Professor and Chairman, Department of Psychiatry, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, will also be presented – an educational tool for schizophrenia that helps teach physicians about common myths and misconceptions, manage frequent clinical dilemmas and identify the latest therapeutic options.

 

This year’s annual APA meeting is being offered both in person and virtually. Abstracts can be accessed here.

 

The full set of data sponsored by Teva includes:

Symposium: Saturday, May 20, 2:00 PM – 3:00 PM PT

  • Guiding the S.C.O.P.E. of schizophrenia care forward through interactive digital education for clinicians

Symposium: Monday, May 22, 12:15 PM – 12:45 PM PT

  • IMPACT-TD scale: A novel tool to assess the true story of the impact of TD in our patients

Poster Session 12: Tuesday, May 23, 1:30 PM – 3:00 PM PT

  • (De novo) Use of Machine-Learning to Identify Unique Patient Segments Within the Tardive Dyskinesia Population (5040)
  • (De novo) Assessment of Underdiagnosis of Tardive Dyskinesia (TD) by Geographic Region, Social Determinants, and Other Patient Characteristics (4939)

Poster Session 13: Tuesday, May 23, 3:45 PM – 5:15 PM PT

  • (De novo) TV-46000, a Long-Acting Subcutaneous Antipsychotic (LASCA) in Schizophrenia: Phase 3 Study (RISE) and Long-Term Safety and Tolerability Study (SHINE) (5523)
  • (De novo) Myths, Misconceptions, and Clinical Dilemmas Surrounding the Use of Long-acting Injectable Antipsychotic Agents for Treatment of Schizophrenia (4779)

About Tardive Dyskinesia (TD)

Tardive dyskinesia (TD) is a highly debilitating, chronic movement disorder that affects one in four people who take certain mental health treatments and is characterized by uncontrollable, abnormal, and repetitive movements of the face, torso, and/or other body parts, which may be disruptive and negatively impact individuals.3-5

 

About Schizophrenia

Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts.8 Patients experience an array of symptoms, which may include delusions, hallucinations, disorganized speech or behavior and impaired cognitive ability.8-10 Approximately 1% of the world’s population will develop schizophrenia in their lifetime, and 3.5 million people in the U.S. are currently diagnosed with the condition.9,10 Although schizophrenia can occur at any age, the average age of onset tends to be in the late teens to the early 20s for men, and the late 20s to early 30s for women.8 The long-term course of schizophrenia is marked by episodes of partial or full remission broken by relapses that often occur in the context of psychiatric emergency and require hospitalization.8 Approximately 80% of patients experience multiple relapses over the first five years of treatment, and each relapse carries a biological risk of loss of function, treatment refractoriness, and changes in brain morphology.11-13 Patients are often unaware of their illness and its consequences, contributing to treatment nonadherence, high discontinuation rates, and ultimately, significant direct and indirect healthcare costs from subsequent relapses and hospitalizations.8-13

 

About UZEDY

UZEDY (risperidone) extended-release injectable suspension, for subcutaneous use, is indicated for the treatment of schizophrenia in adults. In clinical trials, UZEDY reduced the risk of relapse by up to 80%.1 UZEDY administers risperidone through copolymer technology under license from MedinCell that allows for absorption and sustained release after subcutaneous injection. UZEDY is the only long-acting, subcutaneous formulation of risperidone available in both one- and two-month dosing intervals.1 For full prescribing information, visit https://www.uzedy.com/globalassets/uzedy/prescribing-information.pdf.

 

INDICATION AND USAGE

UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for the treatment of schizophrenia in adults.

IMPORTANT SAFETY INFORMATION

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. UZEDY is not approved for use in patients with dementia-related psychosis and has not been studied in this patient population.

CONTRAINDICATIONS: UZEDY is contraindicated in patients with a known hypersensitivity to risperidone, its metabolite, paliperidone, or to any of its components. Hypersensitivity reactions, including anaphylactic reactions and angioedema, have been reported in patients treated with risperidone or paliperidone.

WARNINGS AND PRECAUTIONS

Cerebrovascular Adverse Reactions: In trials of elderly patients with dementia-related psychosis, there was a significantly higher incidence of cerebrovascular adverse events (e.g., stroke, transient ischemic attack), including fatalities, in patients treated with oral risperidone compared to placebo. UZEDY is not approved for use in patients with dementia-related psychosis.

Neuroleptic Malignant Syndrome (NMS): NMS, a potentially fatal symptom complex, has been reported in association with antipsychotic drugs. Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status including delirium, and autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis, and cardiac dysrhythmia). Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure. If NMS is suspected, immediately discontinue UZEDY and provide symptomatic treatment and monitoring.

Tardive Dyskinesia (TD): TD, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements, may develop in patients treated with antipsychotic drugs. Although the prevalence of the syndrome appears to be highest among the elderly, especially elderly women, it is impossible to predict which patients will develop the syndrome. Whether antipsychotic drug products differ in their potential to cause TD is unknown.

The risk of developing TD and the likelihood that it will become irreversible are believed to increase with the duration of treatment and the cumulative dose. The syndrome can develop, after relatively brief treatment periods, even at low doses. It may also occur after discontinuation. TD may remit, partially or completely, if antipsychotic treatment is discontinued. Antipsychotic treatment, itself, however, may suppress (or partially suppress) the signs and symptoms of the syndrome, possibly masking the underlying process. The effect that symptomatic suppression has upon the long-term course of the syndrome is unknown.

If signs and symptoms of TD appear in a patient treated with UZEDY, drug discontinuation should be considered. However, some patients may require treatment with UZEDY despite the presence of the syndrome. In patients who do require chronic treatment, use the lowest dose and the shortest duration of treatment producing a satisfactory clinical response. Periodically reassess the need for continued treatment.

Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes that may increase cardiovascular/cerebrovascular risk. These metabolic changes include hyperglycemia, dyslipidemia, and body weight gain. While all of the drugs in the class have been shown to produce some metabolic changes, each drug has its own specific risk profile.

Hyperglycemia and diabetes mellitus (DM), in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, have been reported in patients treated with atypical antipsychotics, including risperidone. Patients with an established diagnosis of DM who are started on atypical antipsychotics, including UZEDY, should be monitored regularly for worsening of glucose control. Patients with risk factors for DM (e.g., obesity, family history of diabetes) who are starting treatment with atypical antipsychotics, including UZEDY, should undergo fasting blood glucose (FBG) testing at the beginning of treatment and periodically during treatment. Any patient treated with atypical antipsychotics, including UZEDY, should be monitored for symptoms of hyperglycemia including polydipsia, polyuria, polyphagia, and weakness. Patients who develop symptoms of hyperglycemia during treatment with atypical antipsychotics, including UZEDY, should undergo FBG testing. In some cases, hyperglycemia has resolved when the atypical antipsychotic, including risperidone, was discontinued; however, some patients required continuation of antidiabetic treatment despite discontinuation of risperidone.

Dyslipidemia has been observed in patients treated with atypical antipsychotics.

Weight gain has been observed with atypical antipsychotic use. Monitoring weight is recommended.

Hyperprolactinemia: As with other drugs that antagonize dopamine D2 receptors, risperidone elevates prolactin levels and the elevation persists during chronic administration. Risperidone is associated with higher levels of prolactin elevation than other antipsychotic agents.

Orthostatic Hypotension and Syncope: UZEDY may induce orthostatic hypotension associated with dizziness, tachycardia, and in some patients, syncope. UZEDY should be used with particular caution in patients with known cardiovascular disease, cerebrovascular disease, and conditions which would predispose patients to hypotension and in the elderly and patients with renal or hepatic impairment. Monitoring of orthostatic vital signs should be considered in all such patients, and a dose reduction should be considered if hypotension occurs. Clinically significant hypotension has been observed with concomitant use of oral risperidone and antihypertensive medication.

Falls: Antipsychotics, including UZEDY, may cause somnolence, postural hypotension, motor and sensory instability, which may lead to falls and, consequently, fractures or other fall-related injuries. Somnolence, postural hypotension, motor and sensory instability have been reported with the use of risperidone. For patients, particularly the elderly, with diseases, conditions, or medications that could exacerbate these effects, assess the risk of falls when initiating antipsychotic treatment and recurrently for patients on long-term antipsychotic therapy.

Leukopenia, Neutropenia, and Agranulocytosis have been reported with antipsychotic agents, including risperidone. In patients with a pre-existing history of a clinically significant low white blood cell count (WBC) or absolute neutrophil count (ANC) or a history of drug-induced leukopenia or neutropenia, perform a complete blood count (CBC) frequently during the first few months of therapy. In such patients, consider discontinuation of UZEDY at the first sign of a clinically significant decline in WBC in the absence of other causative factors. Monitor patients with clinically significant neutropenia for fever or other symptoms or signs of infection and treat promptly if such symptoms or signs occur. Discontinue UZEDY in patients with ANC < 1000/mm3) and follow their WBC until recovery.

Potential for Cognitive and Motor Impairment: UZEDY, like other antipsychotics, may cause somnolence and has the potential to impair judgement, thinking, and motor skills. Somnolence was a commonly reported adverse reaction associated with oral risperidone treatment. Caution patients about operating hazardous machinery, including motor vehicles, until they are reasonably certain that treatment with UZEDY does not affect them adversely.

Seizures During premarketing studies of oral risperidone in adult patients with schizophrenia, seizures occurred in 0.3% of patients (9 out of 2,607 patients), two in association with hyponatremia. Use UZEDY cautiously in patients with a history of seizures or other conditions that potentially lower the seizure threshold.

Dysphagia: Esophageal dysmotility and aspiration have been associated with antipsychotic drug use. Antipsychotic drugs, including UZEDY, should be used cautiously in patients at risk for aspiration.

Priapism has been reported during postmarketing surveillance for other risperidone products. A case of priapism was reported in premarket studies of UZEDY. Severe priapism may require surgical intervention.

Body temperature regulation. Disruption of the body’s ability to reduce core body temperature has been attributed to antipsychotic agents. Both hyperthermia and hypothermia have been reported in association with oral risperidone use. Strenuous exercise, exposure to extreme heat, dehydration, and anticholinergic medications may contribute to an elevation in core body temperature; use UZEDY with caution in patients who experience these conditions.

ADVERSE REACTIONS

The most common adverse reactions with risperidone (≥5% and greater than placebo) were parkinsonism, akathisia, dystonia, tremor, sedation, dizziness, anxiety, blurred vision, nausea, vomiting, upper abdominal pain, stomach discomfort, dyspepsia, diarrhea, salivary hypersecretion, constipation, dry mouth, increased appetite, increased weight, fatigue, rash, nasal congestion, upper respiratory tract infection, nasopharyngitis, and pharyngolaryngeal pain.

The most common injection site reactions with UZEDY (≥5% and greater than placebo) were pruritus and nodule.

DRUG INTERACTIONS

  • Carbamazepine and other strong CYP3A4 inducers decrease plasma concentrations of risperidone.
  • Fluoxetine, paroxetine, and other strong CYP2D6 inhibitors increase risperidone plasma concentration.
  • Due to additive pharmacologic effects, the concomitant use of centrally-acting drugs, including alcohol, may increase nervous system disorders.
  • UZEDY may enhance the hypotensive effects of other therapeutic agents with this potential.
  • UZEDY may antagonize the pharmacologic effects of dopamine agonists.
  • Concomitant use with methylphenidate, when there is change in dosage of either medication, may increase the risk of extrapyramidal symptoms (EPS)

USE IN SPECIFIC POPULATIONS

Pregnancy: May cause EPS and/or withdrawal symptoms in neonates with third trimester exposure. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including UZEDY, during pregnancy. Healthcare providers are encouraged to register patients by contacting the National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or online at http://womensmentalhealth.org/clinicaland-research-programs/pregnancyregistry/.

Lactation: Infants exposed to risperidone through breastmilk should be monitored for excess sedation, failure to thrive, jitteriness, and EPS.

Fertility: UZEDY may cause a reversible reduction in fertility in females.

Pediatric Use: Safety and effectiveness of UZEDY have not been established in pediatric patients.

Renal or Hepatic Impairment: Carefully titrate on oral risperidone up to at least 2 mg daily before initiating treatment with UZEDY.

Patients with Parkinson’s disease or dementia with Lewy bodies can experience increased sensitivity to UZEDY. Manifestations and features are consistent with NMS.

Please see the full Prescribing Information for UZEDY, including Boxed WARNING.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and innovative medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of innovative and biopharmaceutical products. Learn more at www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to the development and commercial success of UZEDY (risperidone) extended-release injectable suspension for the treatment of schizophrenia; our ability to successfully compete in the marketplace, including our ability to develop and commercialize competition for our innovative medicines, our ability to achieve expected results from investments in our product pipeline, our ability to develop and commercialize additional pharmaceutical products, and the effectiveness of our patents and other measures to protect our intellectual property rights; our substantial indebtedness; our business and operations in general, including, the impact of global economic conditions and other macroeconomic developments and the governmental and societal responses thereto, and costs and delays resulting from the extensive pharmaceutical regulation to which we are subject; compliance, regulatory and litigation matters, including failure to comply with complex legal and regulatory environments; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the first quarter of 2023 and in our Annual Report on Form 10-K for the year ended December 31, 2022, including in the section captioned “Risk Factors.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

________________________

1 UZEDY™ (risperidone) extended-release injectable suspension, for subcutaneous injection Current Prescribing Information. Parsippany, NJ. Teva Neuroscience, Inc.

2 Kane J, Sharon N. TV-46000, a Long-Acting Subcutaneous Antipsychotic (LASCA) in Schizophrenia: Phase 3 Study (RISE) and Long-Term Safety and Tolerability Study (SHINE). American Psychiatric Association’s 2023 Annual Meeting; 2023. May 20-24. Hybrid congress.

3 Warikoo N, Schwartz T, Citrome L. Tardive dyskinesia. In: Schwartz TL, Megna J, Topel ME, eds. Antipsychotic Drugs. Hauppauge, NY: Nova Science Publishers. 2013:235-258.

4 Waln O, Jankovic J. An Update on Tardive Dyskinesia: From Phenomenology to Treatment. Tremor Other Hyperkinet Mov. 2013;3:1-11.

5 Tardive dyskinesia. National Alliance on Mental Illness website. https://www.nami.org/Learn-More/Treatment/Mental-Health-Medications/Tardive-Dyskinesia. Accessed May 4, 2023.

6 “A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia. ClinicalTrials.gov, U.S. National Institutes of Health, 2018 (NCT03503318).

Contacts

IR Contacts
Ran Meir +1 (267) 468-4475

Yael Ashman, +972 (3) 914 8262

Sanjeev Sharma +1 (973) 658 2700

PR Contacts
Kelley Dougherty +1 (973) 832-2810

Eden Klein +972 (3) 906 2645

Read full story here

Categories
Art & Life Culture Education Lifestyle Programs & Events

Greater New York high school students recognized for outstanding performance in theatre

NEW YORK — The Broadway Education Alliance is pleased to announce that Jaquel Spivey, Tony® and Grammy® Award-nominated artist for his role in A Strange Loop, will co-host the 2022-23 Roger Rees Awards for Excellence in Student Performance.

Broadway reopens for events

The ceremony will be held at the Professional Performing Arts School (328 West 48th Street) on Sunday, May 21, 2023, at 4:00 p.m. The event is sponsored by Disney Theatrical Group and the Tony® Award-nominated production, Kimberly Akimbo. It features two musical production numbers featuring the 54 Roger Rees Awards nominees and 12 solo performances by award finalists. Tickets are currently on sale at rogerreesawards.com.

To be eligible to participate in The Roger Rees Awards, a student must have performed a qualifying role in an officially licensed high school production of an eligible show during the 2022-2023 academic year. Students from 53 high schools located throughout the Greater New York area will compete for the title of Outstanding Performer In A Musical before a panel of Broadway judges that include Michael Arden (2023 Tony® Award-nominated Director, Parade), Kiara Brown Clark (Teaching Artist, Disney Theatrical Group), Greg Nobile (Tony Award-winning producer), Merri Sugarman (Tara Rubin Casting), Jeanine Tesori, (Tony Award-winning composer and 2023 nominee for Best Score of Kimberly Akimbo), and Cynthia Thole (Director/Choreographer and Fairleigh Dickinson University faculty).

Two students selected by this panel of Broadway experts will represent the Greater New York region at The Broadway League Foundation’s The Jimmy Awards® (also known as the National High School Musical Theatre Awards®) on June 26th at the Minskoff Theatre.

Broadway Education Alliance and Roger Rees Awards founder Susan Lee noted, “Encouraging and educating students about theatre is vital. These young artists are the next generation of performers and theatre audiences. We strive to inspire interest, nurture talent and to recognize excellence in these emerging theatre artists.”

Prior to the May 21 event, students will have participated in a day-long performance intensive taught by Broadway professionals with extensive performance and teaching credentials. This team will select 12 Roger Rees Awards finalists who will perform a solo from their high school musical at the Roger Rees Awards.

For the complete list of 54 Roger Rees Awards Nominees, click here.

Acting coaches include acclaimed Broadway performers Jason Gotay, Jarvis B. Manning, Shannon Mullen and Correy West. Music Directors are Isaac Harlan(Broadway Inspirational Voices), Sean Mayes (Hadestown), Julianne B. Merrill (Some Like It Hot), Christine Riley (Marymount Manhattan College). The Roger Rees Awards is directed and choreographed by Theo Lencicki with music direction by Christine Riley.

The Roger Rees Awards is pleased to announce the New Faces | 2023 roster of talented students selected by members of the Casting Society of America as emerging artists to watch.

For the Roger Rees Awards New Faces | 2023 Roster, click here.

Working in partnership with Harmony Helper®, The Roger Rees Awards will also recognize Farmingdale High School’s Daler A Cappella, a 15-member choral group under the direction of Jessica Mischke, with the Outstanding Choral Performance Award.

Theatrely.com with present The Roger Rees Awards online live pre-show special hosted by Tyler Joseph Ellis on Sunday, May 21 beginning at 3:00 pm. Go to Theatrely.com for details.

 

The Roger Rees Awards recognize the importance of theatre arts education and celebrate the exceptional life and career-long artistic excellence of Broadway’s beloved actor/director, Roger Rees. Playwright Rick Elice, Rees’ partner of over 30 years, and author of “Finding Roger,” said, “Rog would have liked this chance to educate and inspire young actors, to offer a guiding hand as so many were offered to him when he too was a kid with a dream.”

The Broadway Education Alliance is the fiscal sponsor for The Roger Rees Awards for Excellence in Student Performance, which is supported by Disney Theatrical Group, Broadway Plus, Broadway HD, Douglas Denoff, Rick Elice, Nancy Nagel Gibbs, Harmony Helper, Kimberly Akimbo on Broadway, Music Theatre International, National Foundation of Musical Theatre, Theatrical Rights Worldwide, Withum and many other industry leaders working in/around Broadway.

Tickets are currently on sale at rogerreesawards.com.

Categories
Environment Lifestyle Local News Programs & Events

D&R Greenway Land Trust hosts GSWS juried exhibition on migration

D&R Greenway Land Trust is now hosting the Garden State Watercolor Society (GSWS) for its 53rd Annual Open Juried Exhibition,“Migration: Movement for Survival.”

Photo: “New Jersey Shore Scene” by Richard Hoffman

 

 

GSWS artists created their art to contemplate migration and change – a growing phenomenon in today’s world. Whether figurative or abstract, realistic or fanciful, this thoughtful art will inspire and cause the viewer to think and reflect on the state of the world’s people, wildlife and climate.

 

 

This exhibition is on display May 3 through Sept. 24, 2023, as well as online at www.gswcs.org. The exhibition at D&R Greenway Land Trust’s Johnson Education Center is at One Preservation Place, Princeton NJ 08540.

 

GSWS will host two Zoom Happy Hours with D&R Greenway Land Trust and the Conserve Wildlife Foundation of NJ which are open to the public with preregistration, on May 25 and June 22, 5-6 p.m. Each will be a mashup of art and science highlighting Migratory Bats and Birds as well as artists discussing their work. Data will be included on bats and birds observed during early data-gathering at D&R Greenway’s newest Hillside Farm Preserve in Hopewell.

Photo: Best in Show: “It’s Time for School” by Kristen Birdsey

 

The Juried Exhibition’s Opening Reception and Awards Ceremony will be held June 11, 2-4 pm. GSWS is grateful to the New Jersey Audubon Society for several new artist awards this year.

 

 

Juror for acceptance and awards is Michael Kowbuz. Discover more about him at https://tinyurl.com/4vv7xnvk.
The award winners are:

 

 

 

Award                                                                                       Artist                                 Painting Title

Best in Show – Dagmar Tribble Award                         Kristen Birdsey              It’s Time for School

Nummie Warga Award                                                      Gloria Wiernik                Shifting Sands

Cotswold Industries Award                                             Joanne Bodnar              For the Birds 2

Albert Hunker Memorial Award                                    Zina Umyn                      Voyagers

NJ Audubon – Northern Harrier Award                       Peter Zdenek                  Wildebeest Migration

NJ Audubon – Red Shouldered Hawk Award            Doris Ettlinger                Snow Geese

NJ Audubon – Piping Plover Award                               Joanne Amantea           Fueling Migration

NJ Audubon – Peregrine Falcon Award                        Catherine Gowen         Herbarium at the Little Colorado River

Golden Artist Colors Materials Award                         Medha Atre-Kulkarni  Pursuing Sweetness

GSWS Silver Memorial Award – Marthe McKinnon                                           Kathleen Wert   Storm

NJ Watercolor Society Award                                         Kara Coleman                Park Landscape

Holbein Artists Materials Award                                   Barbara March              And Just Like That, Winter Melts into Spring

 

People’s Choice Award – Jerry’s Artarama (Visitors votes will be tallied and award will be given Sept. 24).

Poetry workshops, led by renowned local poets in partnership with D&R Greenway, will result in a Poetry Reading on the theme of migration, and a Gallery Walk hosted by GSWS, on Sept. 21, beginning at 6:30 p.m.

 

An Artist Demo, by award-winning GSWS artist Ann Greene, will take place as a culmination of the exhibition, Sept. 24 from 2 to 4 p.m. New awards donated by the New Jersey Audubon Society will be added to the Awards Ceremony June 11. For most recent information, visit www.gswcs.org.

 

Artists researched and learned about the complex phenomenon of migration to create work that is meaningful to the exhibition theme. Migration is most often thought of as the seasonal movement of animals. Species in all major animal groups migrate. Some species travel astounding distances to reach environments that provide food and conditions for successful mating. Migration also relates to the movement of people. Currently and throughout history, people have left their homes voluntarily or involuntarily to seek safety and opportunity. Climate change is affecting the earth’s inhabitants globally and regionally at a quicker pace than anticipated. As glaciers melt and sea levels rise, weather patterns have become dangerous and unpredictable. As a result, whole communities of people, animals and even plants migrate in order to survive.

Photo: “La Esperanza, “Cuban Migrant Boat, Florida Keyes” by Sandy Mezinis, AWS

 

Linda Mead, President and CEO of D&R Greenway had this to say: “Among the most electrifying movements of our time is the migration of plants due to climate change and the effect on birds and wildlife that have evolved with these plants for their very survival. Likewise, human populations are migrating in great numbers. All of this has an impact, from what we see today on D&R Greenway preserves, to the survival of many species of the Earth. Remember, we are the top of the food chain and if we don’t do something to care for our natural and social climates, our own survival is at stake, too.”

 

A unique display upon entering the Johnson Education Center lobby will be GSWS’ 5th Annual Art Installation, “Going, Going, Gone…” “Fifty-three GSWS artists created 123 beautiful small works that call attention to New Jersey species identified by NJDEP as in greatest need of our conservation efforts. Artists submitted paintings of animals using a designated color scheme. GSWS is proud to partner with the D&R Greenway Land Trust to inform and inspire people into action.” said Tess Fields, President of GSWS. “This exhibit is another exciting intersection of science and art that will capture wide audience attention.”

 

Over its existence, GSWS has been a beacon for award-winning artists to inspire generations. The nonprofit organization’s goal is to encourage painting in water media, provide educational and exhibition opportunities for adult artists of NJ, PA, NY or DE. Please visit www.gswcs.org.

 

The public is invited to visit the art galleries, weekdays 10 am – 4 p.m. Open select weekends, hosted by GSWS artists, July 8-9 and Aug. 5-6 from 10 a.m. – 4 p.m. Closed holidays. Visit www.drgeenway.org or call 609-924-4646 for more info.

 

BACKGROUND:

Garden State Watercolor Society has led a community of artists and inspired generations of art enthusiasts. The society’s founding goal is to encourage painting in watermedia and provide educational and exhibition opportunities for artists and residents of NJ, PA, NY or DE. GSWS holds three exhibitions a year including our largest endeavor, the Annual Open Juried Exhibition (hybrid); an online Members Exhibition; hybrid Small but Mighty Exhibition, and a live Art Sale via pop up gallery in Princeton. In May 2023, they will showcase a permanent exhibit of botanical-style watercolors inside of the Discovery Center at the former estate of Joseph Bonaparte at Point Breeze, Bordentown, NJ.

 

About D&R Greenway Land Trust: D&R Greenway Land Trust is an accredited nonprofit that has reached a new milestone of over 22,000 acres of land preserved throughout central New Jersey since 1989. By protecting land in perpetuity and creating public trails, it gives everyone the opportunity to enjoy the great outdoors. The land trust’s preserved farms and community gardens provide local organic food for residents of the region—including those most in need. Through strategic land conservation and stewardship, D&R Greenway combats climate change, protects birds and wildlife, and ensures clean drinking water for future generations. D&R Greenway’s mission is centered on connecting land with people from all walks of life. www.drgreenway.org; info@drgreenway.org. Follow us on Facebook and Instagram.

Categories
Business Culture Economics Lifestyle Programs & Events

ezCater brings Wawa’s signature Sizzli® sandwich and hoagies to workplaces across the Mid-Atlantic and Florida

Businesses can now order Wawa Catering from all 1,000 stores through the ezCater marketplace

 

BOSTON — (BUSINESS WIRE) — ezCater, the most trusted provider of corporate food solutions, and Wawa Inc.  announced Tuesday, the launch of all Wawa locations on the ezCater marketplace. Now, workplaces can order Wawa’s signature breakfast sandwiches, like the Sizzli®, and hoagies, from 1,000 store locations across Pennsylvania, Delaware, New Jersey, Maryland, Virginia, Florida, and Washington, D.C.


​“Thanks to this new partnership with ezCater, we now have the ability to reach more business customers with our fresh offers, perfect for breakfast, meetings, and corporate events,” said Steve Hackett, Director of Digital Experience, Wawa.

 

“We see this as a great way to provide even more convenience to the business community.”

 

In a recent survey, ezCater found that 67% of workers believe that skipping breakfast negatively affects their productivity in the workplace. Still, 60% of them skip breakfast two or more days per week, creating a big opportunity for employers to improve productivity by providing breakfast. With ezCater, Wawa can now reach these valuable business customers investing in food for work. Their catering menu includes a variety of breakfast, coffee, and lunch items, which come individually packaged or in trays, depending on the workplace’s needs.

 

“Our customers count on us to provide a variety of reliable caterers for all of their food for work needs, whether that’s for breakfast meetings, daily employee lunches, or anything in between,” said Mike O’Hanlon, Chief Partnership Officer, ezCater.

 

“Wawa’s iconic lunch staples and breakfast options like the Sizzli® make them fan-favorites. We’re so excited to now be able to offer Wawa Catering to ezCater customers.”

 

ezCater has more than 100,000 restaurants and caterers on its platform, from local independent restaurants to national chains. With its extensive expertise in corporate food solutions, ezCater helps its restaurant partners manage, analyze, and grow their catering businesses. To learn more about the ezCater Catering Growth Platform, visit www.ezcater.com/grow.

 

To place a catering order from Wawa, visit www.ezcater.com/brand/wawa-1.

 

Methodology

In March of 2023, ezCater surveyed 500 workers nationwide, that work onsite in a business office or hybrid, to analyze the role breakfast has on employee health, productivity, and satisfaction.

 

About ezCater

ezCater is the most trusted provider of corporate food solutions. With a network of more than 100,000 restaurants across the US on its platform, ezCater provides flexible and scalable food solutions for everything from recurring employee meals to one-off events such as sales calls and board meetings. ezCater is purpose-built for food for work and supported by best-in-class customer service, enabling companies to centralize and manage their food spend in a single, customizable platform. To explore corporate food solutions or place a catering order, visit www.ezcater.com.

 

About Wawa, Inc.

Wawa, Inc., a privately held company, began in 1803 as an iron foundry in New Jersey. Toward the end of the 19th Century, owner George Wood took an interest in dairy farming and the family began a small processing plant in Wawa, PA in 1902. The milk business was a huge success, due to its quality, cleanliness and “certified” process. As home delivery of milk declined in the early 1960s, Grahame Wood, George’s grandson, opened the first Wawa Food Market in 1964 as an outlet for dairy products. Today, Wawa is your all day, every day stop for freshly prepared foods, beverages, coffee, fuel services and surcharge-free ATMs. Wawa stores are located in Pennsylvania, New Jersey, Delaware, Maryland, Virginia, Florida and Washington, D.C. The stores offer a large fresh foodservice selection, including Wawa brands such as custom prepared hoagies, freshly-brewed coffee, hot breakfast sandwiches, specialty beverages and an assortment of soups, sides and snacks. Forbes.com Ranks Wawa as #24 of America’s Largest Private Companies in 2021 and #12 on Forbes 100 Halo List in 2022. For more information, visit us on www.wawa.com or follow us on Facebook, Twitter, Instagram, TikTok, and Snapchat at @wawa.

Categories
Culture Government Local News Politics Programs & Events

County Clerk says to look for the arrival of Vote by Mail ballots, now

TRENTON, N.J. — Mercer County Clerk Paula Sollami Covello announces that the County has begun to mail out Vote by Mail ballots for the upcoming June 6 Primary Election, to voters.

 

For those wishing to apply to vote by mail, applications are to be returned to the County Clerk’s office, located at 209 South Broad Street, 2nd floor, Trenton, no later than May 30. Applications can be found online NJ DOS – Division of Elections – Vote-By-Mail (state.nj.us)

 

The deadline for voters that wish to drop off their vote by mail ballot in person, at the Clerk’s office, is June 5, at 3 p.m. The County Clerk cannot accept faxed or emailed copies of an application for a vote by mail ballot unless you are a military or overseas voter, since an original signature is required. To request an absentee ballot, click NJ DOS – Division of Elections – Vote-By-Mail (state.nj.us).

 

Voted ballots for the June 6 primary may be returned to any drop box location within Mercer County by 8 p.m. on June 6. They may also be returned to the Mercer County Board of Elections, located at 930 Spruce Street, Trenton, by that same deadline. You can track your ballot here, NJ DOS – Division of Elections – Track My Ballot (state.nj.us).

 

Early voting will be held from June 2 to June 4, Friday and Saturday: 10 a.m. to 8 p.m., and Sunday from 10 a.m. to 6 p.m. Early voting locations can be found Elections | Mercer County, NJ.

 

For more information, visit the Clerk’s election page, New Jersey Department of State – Division of Elections – NJ Voter Information Portal, or call Sue Hansen at 609-989-6495.

Categories
Culture Environment Lifestyle Local News Programs & Events Science

Mercer County Park Commission celebrates Earth Day, Arbor Day by planting trees

Green industry organizations and professionals celebrate Arbor Day Friday, April 28 with the collaborating event of planting of 20 “Jersey Grown” native trees by the Mercer County Park Commission – John A. Roebling Memorial Park at the Hamilton-Trenton border.

Photo: A group from ISLES Climate Corps plant trees and shrubs at Mercer Meadows.

Volunteers will gather at the Spring Lake section of the park, off Sewell Avenue, at 10:30 a.m. to plant native trees appropriate for the site conditions.

The Park Commission looks forward to hosting the NJ Nursery and Landscape Association (NJNLA), The NJ Chapter of the International Society of Arboriculture, Richard A. McCoy Horticultural Services LLC, the Northeast Organic Farming Association of NJ and the NJ Green Industry Council and thanks them for their generous donation of native trees.

A tree planting demonstration will be given by McCoy Horticultural Services as part of the volunteer planting event.

The Park Commission’s Stewardship Department celebrated Earth Day by hosting volunteer groups to help plant native trees and shrubs last week.

Photo: Staff from First Trust Bank plants native trees and shrubs along the Lawrence -Hopewell Trail in Mercer Meadows

 

The volunteer groups included ISLES Climate Corps, First Bank staff from Lawrence Township, Students from the College of New Jersey, Tulpehaking Nature Center staff and New Jersey Watershed Ambassadors.

 

With the help of these generous organizations, over 600 native plants were installed at Mercer Meadows in Pennington, NJ. Over the course of three weeks, a total of 1,400 native shrubs and trees will be planted to replace invasive vegetation that was removed from Mercer Meadows.

 

The County thanks all the volunteers for their hard work!

Categories
Culture Lifestyle Local News Programs & Events Sports & Gaming Travel & Leisure Weather & Environment

Mercer County Park Commission plans their ‘Come Out and Play’ for an overnight in May at Rosedale Park!

HOPEWELL TOWNSHIP, N.J. — The campfire will be crackling, children will be laughing and stars will be visible in the night sky during the Mercer County Park Commission’s Come Out and Play Campout scheduled for Saturday, May 20 to Sunday, May 21, weather permitting.

 

Families will be able to spend the night at Rosedale Park and experience the park like never before. The Come Out and Play Campout is designed to provide a unique summer experience. Cost for in-county residents is $25 per person; out-of-county residents, $35 per person.

 

Join us for naturalist-led stargazing and nighttime games. There will also be live music, roasting hot dogs and s’mores by the campfire. Wrap up the event the next morning by enjoying a complimentary breakfast, an early bird-walk or family craft before heading home. Registration opens Monday, May 1.

 

Registration is open to individuals and families with children ages 6 and over. Children under 18 years old will not be permitted to attend without a registered adult. Pets and alcohol are not allowed.

Register on Community Pass at http://register.communitypass.net/mercer

For more information, email natureprograms@mercercounty.org or call (609) 888-3218.

Categories
Business Education Lifestyle Programs & Events Science Technology

Ten schools named National Finalists in Samsung’s Solve for Tomorrow STEM competition

Students’ Creative Solutions to Community Issues Earn Each Finalist School $50,000 in Samsung Technology & Supplies

 

RIDGEFIELD PARK, N.J. — (BUSINESS WIRE) — Samsung Electronics America today named 10 National Finalist schools from among this year’s 50 State Winners in the 13th annual Samsung Solve for Tomorrow competition. Each National Finalist will receive a prize package of $50,000 in Samsung technology and supplies.

 

Solve for Tomorrow challenges public school students in grades 6-12 to use science, technology, engineering, and math (STEM) skills to create positive change in their communities. The students behind the Finalists’ innovative projects, which address reducing food waste and insecurity, helping unhoused refugees, subway safety, accessibility, and water quality, will pitch their ideas on May 15, 2023 to a panel of judges at a live event in Washington, D.C. Three schools will then be chosen as National Winners and receive $100,000 in prizes.

 

“After three years of COVID disruptions that impacted students and educators alike, it’s been incredibly rewarding to see our Samsung Solve for Tomorrow competition play a part in re-energizing the ingenuity and creativity that had been hobbled by remote learning and isolation for STEM students,” said Ann Woo, Senior Director, Corporate Citizenship, Samsung Electronics America. “The cooperative, hands-on, problem-solving focus of the Solve for Tomorrow challenge provided a spark for students looking to channel their energies to tackle issues that they see in their communities. These National Finalist students, teachers, and schools exhibit what we call STEMpathy – the use of STEM to help fix the issues they see affecting their friends and neighbors, people they EMPATHIZE with.”

 

All 50 State Winners in the prior round of the Solve for Tomorrow competition produced a three-minute video describing their project, the local community issue it addresses, and their proposed STEM-based solution. The National Finalists were selected based on their videos. Between now and May 15, 2023, the general public can vote online for one Community Choice Winner from among the pool of 10 National Finalists, who will win an additional $10,000 prize package. To choose your favorite Solve for Tomorrow Community Choice STEM solution, check out the Finalists’ videos, which can be viewed here:

 

SCHOOL

CITY/STATE

COMMUNITY ISSUE & STEM SOLUTION

Brandywine High School

Wilmington, DE

AACU Switch – AACU Switch eliminates cost barriers by creating an affordable alternative to assistive tech devices for people with independent living disabilities, costing a fraction of the market standard.

Strawberry Crest High School

Dover, FL

Human Health Band – The Human Health Band is a wearable sensor with an app that allows coaches to monitor athlete’s body temperatures and prevent heat related death.

Richmond Hill Middle School

Richmond, GA

Safe Sleep – Safe Sleep’s purpose is to detect sudden increases in heart rate during a PTSD nightmare. This will trigger a companion app to play breathing exercises.

Bloomington High School South

Bloomington, IN

Temp Mural – Temp Mural reduces the impact of global warming by engineering mural art using highly reflective, climate-positive barium sulfate paint.

Merrimack Valley High School

Penacook, NH

Shelby – Shelby combats rising phosphorus levels in bodies of water with a turtle-shaped battery-powered robot with mechanical and chemical filters.

Santa Teresa High School

Santa Teresa, NM

The Living Lumbre – The Living Lumbre is a smart solar-powered heated mat in response to the large flow of refugees who have ended up homeless in our community.

Doral Academy of Northern Nevada

Reno, NV

Food Waste App – The Food Waste App diminishes food waste/insecurity and reduce greenhouse gas emissions by connecting food producers with people to convert produce into meals.

Liberty Avenue Middle School

Brooklyn, NY

Subsave – Subsave is an alert sensor within an app that will work along with the MTA help points to support commuters by discreetly reporting either a 911 emergency to police or a mental health emergency to mobile mental health responders.

Porter High School (Autumn D.)

Porter, TX

HiveHub – HiveHub is a state-of-the-art beehive monitoring system capable of recording the hive traffic, climate, and activity, all the while giving live feedback through the user-friendly app.

Greenbrier East High School

Lewisburg, WV

Mining Sensor – Mining Sensor assists with and expedites locating and rescuing lost cavers by sending a digital signal from the cavers to the surface.

 

“It was a difficult process for the judges to winnow down the full set of fifty State Winners to our ten National Finalists,” added Woo. “All the Samsung Solve for Tomorrow teams showed tremendous determination to help their communities. They worked hard on their projects and video presentations. And we believe that all State Winner teams deserve to be seen and celebrated as the talented and compassionate STEM heroes they truly are.”

 

Up next in the Samsung Solve for Tomorrow competition:

  • The 10 National Finalists will head to a live Pitch Event on May 15 in Washington, D.C. Judges will then select three National Winners, who will each receive $100,000 in prizes.
  • One of the 50 State Winners will be honored as our Sustainability Innovation Award Winner, receiving an added $50,000 prize package of eco-conscious classroom technology.
  • Of the 10 National Finalists, one will be named Community Choice Winner through online public voting, receiving an additional $10,000 in Samsung technology. To participate, simply view the student-created videos on the Samsung Solve for Tomorrow website and cast your vote. Voting is permitted once a day until 11:59 p.m. EDT on May 15, 2023.
  • Samsung employees will name one team this year’s Employee Choice Winner. That honor earns the winning school an added $10,000 of Samsung technology on top of their national winnings.

 

Across all award categories in Solve for Tomorrow, more than $2 million* in Samsung technology and classroom supplies will be distributed in the 2022-23 competition.

 

As part of Samsung’s guiding vision of ‘Together for Tomorrow! Enabling People’, Solve for Tomorrow launched in 2010 to encourage innovative thinking, creative problem-solving, and teamwork to address the most pressing issues impacting society. To date, Samsung Solve for Tomorrow has awarded $24 million in classroom technology and materials to 2,791 public schools in the United States.

 

To learn more about the national STEM competition, please visit www.samsung.com/solve or follow us on Instagram or Facebook.

*$2 million prize is based on an estimated retail value.

Contacts

Media: Nancy Zakhary, SamsungSFT@relev8.co